A tailored Care Home Clinical Assessment Tool (CHCAT) for front line clinicians
A tailored Care Home Clinical Assessment Tool (CHCAT) for front line clinicians
批准号:
10083496
负责人:
金额:
$31.87万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DemDx will deliver an urgently needed Care Home focused Clinical Assessment Tool (CHCAT).The need is driven by the introduction of the Enhanced Health in Care Homes initiative-aimed at providing a more proactive health service to the elderly and frail care home residents by increasing frontline clinical support to care home nursing staff, community rapid response teams led primarily by Allied Healthcare Professionals (AHPs).Care home nursing staff and communities teams require expanded generalist knowledge across hundreds of conditions, signs, symptoms and "red flags," recognition of patient-specific comorbidities, and awareness of frequently updated gold standard protocols. These clinicians are urgently calling for tools to support them in their expanded roles.Currently both community and care home clinical teams rely heavily on clinical guidance from GP surgeries (with knock on impact on GP workloads and waiting lists) or over-refer patients to A&E, putting further pressure on acute care pathways including ambulance call outs..CHCAT builds upon DemDx's sector-leading clinical reasoning intelligent support platform (CRISP), co-developed via InnovateUK and NIHR-funded engagement in five NHS Trusts. It is the gold standard in support tools for allied health professionals.CHCAT will be a revolutionary cloud-based clinical assessment tool, using AI and data to support community/care home staff in better, safer, quicker clinical assessment and treatment or referral decisions.Innovations include:* AI allowing dynamic consideration of complex patterns and associations across 10,000s of symptoms, comorbidities and "red flags" in validated NICE data.* A data-driven structure enabling AHPs to make sense of complex data associations to make safe, consistent decisions, with patient-centric data weighting enabling prioritisation of most probable conditions, to inform best referral options* Powered by a 12m-patient CPRD dataset.* Outputs are tailored to ageing-specific clinical assessment pathways for the 5+ most common ailments* CHCAT is fully interoperable, seamlessly integrated into patient primary care/acute pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于CARE解码框架的跨范式肌电无声语音识别新方法
-
批准号:2026JJ70025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭欣
-
依托单位:
CarE06介导朱砂叶螨对甲氰菊酯对映体代谢抗性形成差异机制
-
批准号:CSTB2023NSCQ-MSX0916
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:张平
-
依托单位:
棉铃虫羧酸酯酶CarE001G在杀虫剂代谢和抗性中的作用及机制
-
批准号:U1903111
-
项目类别:联合基金项目
-
资助金额:57万元
-
批准年份:2019
-
负责人:李永强
-
依托单位:
棉铃虫羧酸酯酶CarE001C定向进化及突变酶的结构与功能研究
-
批准号:31201517
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:李永强
-
依托单位: